Results 141 to 150 of about 6,902 (197)

Successful optical genome mapping from 500 000 cells: A low-input UHMW DNA extraction approach. [PDF]

MethodsX
De Vlieghere E, Nollet F, Devos H, Cauwelier B.   +3 more
europepmc   +1 more source

Rapid evolution of malaria parasite density and standardization of thick smear examination for epidemiological investigations [PDF]

, 1985
Trape, Jean-François
core  

Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapy. [PDF]

Res Pract Thromb Haemost
Foulon-Pinto G, Jourdi G, Delrue M, Lafuente-Lafuente C, Cavalie C, Gouin-Thibault I, Le Guen J, Gaussem P, Mirault T, Puymirat E, Lecompte T, Pautas E, Curis E, Siguret V.   +13 more
europepmc   +1 more source

Drive to survive: gene dependency in T-cell acute lymphoblastic leukemia. [PDF]

Haematologica
Andrieu GP, Asnafi V.
europepmc   +1 more source

Central nervous system relapse of an extranodal natural killer/T-cell lymphoma. [PDF]

EJHaem
Chiriac R, Baseggio L, Golfier C.
europepmc   +1 more source

Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients. [PDF]

J Hematol Oncol
Alcantara M, Chevrier M, Jardin F, Schmitt A, Houillier C, Oberic L, Chinot O, Morschhauser F, Peyrade F, Houot R, Hoang-Xuan K, Ghesquieres H, Soussain C.   +12 more
europepmc   +1 more source

Energy drinks consumption and association factors among medical science students in Syria: A cross-sectional study. [PDF]

Medicine (Baltimore)
Salem M, Kahwaji A, Al Asadi L, Hourania Y, Mhawesh R, Nasab E, Alsuliman T.   +6 more
europepmc   +1 more source

Always more "setrons”: How many do we need? [PDF]

, 2018
Aapro, Matti
core  

Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia. [PDF]

Leukemia
Sharman JP, Egyed M, Jurczak W, Skarbnik A, Pagel JM, Flinn IW, Kamdar M, Munir T, Walewska R, Corbett G, Fogliatto LM, Herishanu Y, Banerji V, Coutre S, Follows G, Walker P, Karlsson K, Ghia P, Janssens A, Cymbalista F, Woyach JA, Ferrant E, Wierda WG, Munugalavadla V, Yu T, Wang MH, Byrd JC.   +26 more
europepmc   +1 more source